Residents of Afghanistan, Angola, Burundi, Benin, Burkina Faso, Bangladesh, Bhutan, Central African Republic, Côte d’Ivoire, Cameroon, Congo, Dem. Rep., Congo, Rep., Comoros, Cabo Verde, Djibouti, Algeria, Egypt, Arab Rep., Eritrea, Ethiopia, Micronesia, Fed. Sts., Ghana, Guinea, Gambia, The, Guinea-Bissau, India, Iran, Islamic Rep., Jordan, Kenya, Kyrgyz Republic, Cambodia, Kiribati, Lao PDR, Lebanon, Liberia, Sri Lanka, Lesotho, Morocco, Madagascar, Mali, Myanmar, Mongolia, Mozambique, Mauritania. Malawi, Niger, Nigeria, Nepal, Pakistan, Philippines, Papua New Guinea, Korea, Dem. People’s Rep., Rwanda, Sudan, Senegal, Solomon Islands, Sierra Leone, Somalia, South Sudan, Eswatini, Syrian Arab Republic, Chad, Togo, Tajikistan, Timor-Leste, Tunisia, Tanzania, Uganda, Ukraine, Uzbekistan, Vietnam, Vanuatu, Samoa, Yemen, Rep., Zambia and Zimbabwe

Residentes de Afghanistan, Angola, Burundi, Benin, Burkina Faso, Bangladesh, Bhutan, Central African Republic, Côte d’Ivoire, Cameroon, Congo, Dem. Rep., Congo, Rep., Comoros, Cabo Verde, Djibouti, Algeria, Egypt, Arab Rep., Eritrea, Ethiopia, Micronesia, Fed. Sts., Ghana, Guinea, Gambia, The, Guinea-Bissau, India, Iran, Islamic Rep., Jordan, Kenya, Kyrgyz Republic, Cambodia, Kiribati, Lao PDR, Lebanon, Liberia, Sri Lanka, Lesotho, Morocco, Madagascar, Mali, Myanmar, Mongolia, Mozambique, Mauritania. Malawi, Niger, Nigeria, Nepal, Pakistan, Philippines, Papua New Guinea, Korea, Dem. People's Rep., Rwanda, Sudan, Senegal, Solomon Islands, Sierra Leone, Somalia, South Sudan, Eswatini, Syrian Arab Republic, Chad, Togo, Tajikistan, Timor-Leste, Tunisia, Tanzania, Uganda, Ukraine, Uzbekistan, Vietnam, Vanuatu, Samoa, Yemen, Rep., Zambia y Zimbabwe

Topics & Session Formats

1.


Hypertension care with multidisciplinary teams and standardized processes.

2.


Application of telemedicine and the new remote patient monitoring techniques.

3.


Predictive and analytical models of response to non-pharmacological and pharmacological therapies.

4.


Evaluation and treatment of special populations: elderly, ethnic groups, minorities, frail and multi-morbid patients.

5.


Applied research and translational medicine: molecular and pathophysiological mechanisms, genetic factors and hypertension in animal models.



Sessions Modalities and Objectives

How-to Sessions: These sessions aim to present the state-of-the-art in current practice, providing additional skills for our colleagues. There are two tracks—one for clinicians and one for basic scientists. Each session typically consists of two or three lectures on specific topics, followed by a Q&A session with the audience.

Scientific Sessions: These sessions focus on presenting original work for discussion. The format includes two speakers giving brief introductory lectures on specific topics, followed by presentations of the three or four highest-ranked abstracts related to those topics.

Coffee ISH: These sessions provide a dedicated time and space to discuss the most novel, original, and disruptive knowledge in the field of hypertension. Typically, two expert chairs moderate the presentation of breakthrough abstracts and facilitate the ensuing discussion.

Forum Discussions: These sessions address topics with some level of controversy in the field, facilitating discussion and potential agreement among experts. The format involves two chairs introducing three speakers and guiding the subsequent discussion.

Need to Know in Hypertension: These sessions aim to deliver essential knowledge, particularly for early-career professionals or those new to specific fields. There are two tracks—one for clinicians and one for laboratory scientists. Each session typically includes two or three lectures on specific topics, followed by a Q&A session.

Featured and Special Presentations: These sessions cover special topics where the field has seen extraordinary advances in a short time. The format includes two chairs and between two to four speakers reviewing the latest developments.

Meet the Experts Sessions: These sessions provide an opportunity for attendees to connect with leading researchers in very specific fields, gaining insights into the future of the field. The format includes two chairs and two or three experts delivering lectures.

Keynote Lectures: These lectures aim to provoke deep thinking and rethinking of the field, delivered by renowned global scientists.

Industry-Sponsored Symposium: These sessions are sponsored by key companies in the hypertension and cardiovascular fields, featuring a variety of topics and formats.

Hot Sessions and Position Paper Sessions: These sessions offer an opportunity for in-depth discussion, agreement, and comparison of new guidelines and scientific position papers that guide practitioners to the best standards of care and practice.

×